FDA approves Optimer's Dificid to treat C. difficile infection

05/30/2011 | Reuters · New York Times (tiered subscription model), The

The FDA approved Optimer Pharmaceuticals' antibiotic Dificid, or fidaxomicin, for treating diarrhea caused by Clostridium difficile. Dificid proved more effective than ViroPharma's vancomycin, a standard antibacterial drug, in sustaining patient response during clinical trials, the agency said.

View Full Article in:

Reuters · New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT